Approval · Notice of Compliance 26146 · 2021

RALIVIA: Notice of Compliance 26146

Issued June 25, 2021

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number: 26146
Date: June 25, 2021
Company: Bausch Health, Canada Inc.Laval, Quebec, Canada
Product type: Prescription Pharmaceutical
Submission: New Drug Submission (NDS)
Submission class: Other

Products in this notice

Brand	DIN	Status today
RALIVIA	02299194	Marketed
RALIVIA	02299208	Marketed
RALIVIA	02299216	Marketed

Medicinal ingredients

TRAMADOL HCL 100 MG per TAB
TRAMADOL HCL 200 MG per TAB
TRAMADOL HCL 300 MG per TAB